Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.
Geneva General Hospital receives $15K foundation grant for X-ray machine
GENEVA — The Finger Lakes Health Foundation has received a $15,000 grant from the Marilyn Lichtman Foundation to support the purchase and installation of a new X-ray machine at Geneva General Hospital. “Our goal is to provide the best possible care to our patients, and offering the most current, state-of-the-art equipment possible helps us do […]
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
GENEVA — The Finger Lakes Health Foundation has received a $15,000 grant from the Marilyn Lichtman Foundation to support the purchase and installation of a new X-ray machine at Geneva General Hospital.
“Our goal is to provide the best possible care to our patients, and offering the most current, state-of-the-art equipment possible helps us do that,” Jeff Murad, director of diagnostics at UR Medicine Finger Lakes Health, said in an announcement. “Our thanks to the Board of The Marilyn Lichtman Foundation for their generosity and partnership in promoting the health and well-being of our community, our mission here at Finger Lakes Health.”
The Marilyn Lichtman Foundation is the legacy of Marilyn Lichtman, a successful business owner in the health and human services field. According to the foundation’s website, “She believed that human comfort rests in the body and the soul, and both should be nourished.” The foundation currently supports a broad range of community services providers including veterans’ services, emergency housing and homeless shelters, food banks, first responders’ organizations, as well as other medical and human services providers.
The Finger Lakes Health Foundation says it cultivates, secures, and stewards philanthropic gifts to support the capital, programmatic and endowment needs of UR Medicine Finger Lakes Health. Gifts to the foundation support programs and special projects of Finger Lakes Health and its affiliated entities across a four-county region in central and western New York: Geneva General Hospital, Soldiers and Sailors Memorial Hospital in Penn Yan, Living Centers at Geneva North and South, Huntington Living Center in Waterloo, The Homestead in Penn Yan, and a variety of physician practices.
AFRL in Rome awards up to $9.5M contract for completion of construction projects
ROME — The Air Force Research Laboratory in Rome has awarded a Texas company a contract worth up to $9.5 million to wrap up some construction projects. KMM-Black Wave, of Lewisville, Texas, was awarded a ceiling $9.5 million indefinite-delivery/ indefinite-quantity type contract for simplified acquisition of base engineering requirements, according to July 1 announcement from
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
ROME — The Air Force Research Laboratory in Rome has awarded a Texas company a contract worth up to $9.5 million to wrap up some construction projects.
KMM-Black Wave, of Lewisville, Texas, was awarded a ceiling $9.5 million indefinite-delivery/ indefinite-quantity type contract for simplified acquisition of base engineering requirements, according to July 1 announcement from the U.S. Department of Defense. This contract provides for completion of minor, non-complex construction projects requiring minimal design.
Work will be performed at sites in Rome, Newport, and Stockbridge, New York, and is expected to be completed by June 30, 2030. This contract was a competitive acquisition, and two offers were received, per the Department of Defense announcement. Fiscal 2025 research, development, test and evaluation funds are being obligated at the time of award.
MACNY expands training offerings with hire of director of training
DeWITT — MACNY, The Manufacturers Association, recently announced the expansion of its training department with the appointment of Steven Maloney as the organization’s director of training. His extensive experience in human resources, leadership development, and continuous improvement initiatives will be key to enhancing MACNY’s training offerings and providing members with the tools and skills needed
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
DeWITT — MACNY, The Manufacturers Association, recently announced the expansion of its training department with the appointment of Steven Maloney as the organization’s director of training.
His extensive experience in human resources, leadership development, and continuous improvement initiatives will be key to enhancing MACNY’s training offerings and providing members with the tools and skills needed to drive their success, the association said in its May 14 announcement
In his new role, Maloney will lead the development and delivery of a wide range of training programs designed to strengthen workforce skills across the manufacturing sector and beyond. He will also be responsible for coaching leaders and HR professionals, with a focus on developing tailored coaching pathways and utilizing 360-degree evaluations, MACNY said.
As a certified John Maxwell coach, trainer, and speaker, Maloney will collaborate with David Freund, MACNY’s chief leadership officer, to expand MACNY’s training offerings within the Maxwell portfolio. Additionally, Maloney will spearhead new content development, including the creation of a Mentor Training Program for MACNY’s Registered Apprenticeship Program, aimed at enhancing mentorship and strengthening the apprenticeship experience.
Maloney brings more than 25 years of experience in the manufacturing sector, having held executive leadership roles at Marquardt Switches North America as the director of human resources-US, and at International Wire Group as the VP of human resources. From 2008-2015, he worked at MACNY, playing a key role in enhancing industry-focused education through programs like Situational Leadership II, Crucial Conversations, and Crucial Accountability. Maloney has a proven track record in leadership development, quality assurance, and continuous improvement, working with high-profile companies such as Chobani, INFICON, Pratt & Whitney, Bristol-Myers Squibb, Lockheed Martin, and Empower FCU, MACNY contends.
“Steven’s deep experience in training, coaching, and leadership development makes him a great fit to drive MACNY’s training programs forward,” Randy Wolken, president and CEO of MACNY, said in the announcement. “His hands-on experience in manufacturing and proven success in coaching and mentoring will be invaluable as we continue to expand and diversify our training offerings to meet the needs of our members and the broader community.”
Maloney will deliver training in several key areas, including supervisory leadership, Lean Six Sigma Yellow Belt, 5S and visual workspace, and crucial conversations, among others. New programs focused on emotional intelligence and other advanced-leadership topics will be developed in the future.
Frankfort site is shovel ready for logistics-center development
FRANKFORT, N.Y. — The Central New York Logisitics Center is being marketed as the largest industrial-development site in New York and New England with space
Lockheed Martin to pay quarterly dividend of $3.30 a share in late September
Lockheed Martin Corp. (NYSE: LMT) recently announced that its board of directors has authorized a third-quarter, 2025 dividend of $3.30 per share. The defense contractor will pay the dividend on Sept. 26, to holders of record as of the close of business on Sept. 2. At Lockheed’s current stock price, the dividend yields about 2.9
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
Lockheed Martin Corp. (NYSE: LMT) recently announced that its board of directors has authorized a third-quarter, 2025 dividend of $3.30 per share.
The defense contractor will pay the dividend on Sept. 26, to holders of record as of the close of business on Sept. 2. At Lockheed’s current stock price, the dividend yields about 2.9 percent on an annual basis.
Lockheed Martin — a Bethesda, Maryland–based global defense-technology company — has two plants in Central New York, in Salina and in Owego, respectively.
Through June 27, Lockheed Martin’s stock price had declined just under 5 percent year to date, and was down almost 2 percent over the last 12 months.
ConMed appoints new independent board chair
ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the greater Utica region, recently announced that it had appointed LaVerne Council to succeed Martha Goldberg Aronson as the new independent chair of its board of directors, effective May 21. Council brings extensive experience as a global operations and information technology executive that has been
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the greater Utica region, recently announced that it had appointed LaVerne Council to succeed Martha Goldberg Aronson as the new independent chair of its board of directors, effective May 21.
Council brings extensive experience as a global operations and information technology executive that has been invaluable to ConMed in her previous service on the board, the company said.
“It’s a privilege to take on the role of Chair of the Board,” Council said in the announcement. “I look forward to continuing to work closely with the Board, Pat [Beyer, president and CEO], and the entire CONMED leadership team on executing the Company’s long-term strategy. We are all focused on empowering healthcare providers to deliver exceptional outcomes for patients, delivering favorable returns for our stockholders, creating an engaging environment for our employees, and driving the long-term success of the business.”
ConMed on July 7 announced that Aronson was stepping down, effective that day, from the company’s board to assume the role of president and CEO of Merit Medical, a company engaged in the development, manufacture, and distribution of proprietary medical devices.
ConMed is a medical technology company that provides devices and equipment for surgical procedures. The firm’s products are used by surgeons and other health-care professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
Based in Largo, Florida since 2021, ConMed still operates a facility on French Road in New Hartford, where it was formerly headquartered.
Oswego Health Medical Practice adopts advanced test to predict esophageal cancer risk
OSWEGO — TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE). The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to this AI-driven precision medicine test, per a June 30 announcement. Offering this test is
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
OSWEGO — TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).
The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to this AI-driven precision medicine test, per a June 30 announcement.
Offering this test is a “major step forward in the Center’s commitment to bringing the latest, evidence-based diagnostic tools to the community,” Oswego Health contends.
BE is the only known precursor to esophageal adenocarcinoma (EAC), one of the fastest-growing cancers in the U.S. Fortunately, BE can be effectively treated to prevent progression to EAC if the patient is identified as having elevated risk, Oswego Health stated.
That’s where TissueCypher comes in: the test evaluates a patient’s tissue biopsy at the cellular and molecular level to provide a personalized five-year probability of progression to high-grade dysplasia (HGD) or esophageal cancer.
No new procedures are needed to run the test — biopsies just need to be sent to Castle Biosciences, the company that developed the TissueCypher test, Oswego Health said.
“Early intervention can be lifesaving, and TissueCypher helps us provide a more accurate picture of an individual’s cancer risk,” Dr. Mohammad Fahad Ali, chief of gastroenterology & hepatology and director of endoscopy at the Center for Gastroenterology & Metabolic Diseases, said.
Dr. Ali spearheaded the initiative to make this test available to the community, Oswego Health noted.
TissueCypher represents a significant improvement over traditional risk assessment methods, which often misclassify patients, per the announcement. The test provides a risk classification: low, intermediate, or high; a risk score on a scale of 0–10; and a 5-year individualized risk of progression to HGD or EAC.
Oswego Health encourages those experiencing chronic acid reflux or who have a family history of BE or esophageal cancer to speak with their health-care provider about screening.
Lockheed wins $78M contract modification for undersea warfare combat systems
SALINA — Lockheed Martin Corp. (NYSE: LMT) has been awarded a $78.4 million modification to a previously awarded contract to exercise the option and provide funding for fiscal 2025 Hypervisor Technology Zero AN/SQQ-89A(V)15 surface ship undersea warfare combat systems and spares in support of the continued AN/SQQ-89A(V)15 development, integration, manufacture, production, and testing. Work will
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
SALINA — Lockheed Martin Corp. (NYSE: LMT) has been awarded a $78.4 million modification to a previously awarded contract to exercise the option and provide funding for fiscal 2025 Hypervisor Technology Zero AN/SQQ-89A(V)15 surface ship undersea warfare combat systems and spares in support of the continued AN/SQQ-89A(V)15 development, integration, manufacture, production, and testing.
Work will be performed in Manassas, Virginia (70 percent); Lemont Furnace, Pennsylvania (15 percent); Lockheed Martin’s plant in the town of Salina (13 percent); Clearwater, Florida (1 percent); and Lockheed’s plant in Owego (1 percent). Work is expected to be completed by February 2028, according to a June 30 contract announcement from the U.S. Department of Defense.
Fiscal 2025 shipbuilding and conversion (Navy) funds of $42.8 million (55 percent); and fiscal 2025 other procurement (Navy) funds totaling $35.6 million (45 percent), will be obligated at the time of award and will not expire at the end of the current fiscal year. The Naval Sea Systems Command in Washington, D.C. is the contracting authority.
Lockheed Martin — a Bethesda, Maryland–based global defense-technology company — has two plants in Central New York, in Salina and in Owego, respectively.
OPINION: One Big Beautiful Bill Act’s Impact on 2026 Midterm Elections
Following the U.S. House and Senate completing their work on the One Big Beautiful Bill Act — enacting much of President Donald Trump’s legislative agenda as he signed it into law on July 4 — Democrats are now shifting their posture toward the 2026 Congressional midterms. They are seeking to reclaim the House and Senate
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
Following the U.S. House and Senate completing their work on the One Big Beautiful Bill Act — enacting much of President Donald Trump’s legislative agenda as he signed it into law on July 4 — Democrats are now shifting their posture toward the 2026 Congressional midterms. They are seeking to reclaim the House and Senate by campaigning against the bill’s provisions.
Not a single Democrat in the House or Senate voted for the One Big Beautiful Bill Act, which makes the 2017 Trump tax cuts permanent, expands tax relief with no income taxes on tips or overtime, cuts income taxes for seniors collecting Social Security, includes 100 percent expensing for factories and agriculture to encourage domestic production, [and many other positive provisions]. The law also provides $170 billion of border and immigration-enforcement provisions, including $46 billion to finish the border wall, $45 billion for new immigration detention centers that can deal with 116,000 detainees, knocks 1.4 million illegal aliens off Medicaid and food stamps, provides 10,000 new Immigration and Customs Enforcement (ICE) officers, [and more].
For President Trump it was his biggest legislative win ever, and will give his administration and Congress some breathing room on the debt ceiling, which was increased by $5 trillion, taking that off the list of “must-pass” bills that will come up again in the next couple years. The remaining bills will include appropriations, whether in the form of individual appropriations bills, an omnibus bill, or another continuing resolution. These are leverage points that will cause President Trump and Republican leaders in Congress to sit down with Democrats to craft presumably stopgap deals to kick the can ahead.
In the meantime, despite all the action in Congress and what remains ahead, not much has changed with the generic Congressional ballot for 2026, with Democrats only leading by 2.3 percentage points, 45 percent to 42.7 percent, according to the latest average compiled by RealClearPolling.com.
Usually a reliable proxy for which direction the country is headed in, the average of generic Congressional ballot polls all predicted the winner of the 2002, 2006, 2010, 2014, 2018 and 2022 midterm elections.
In 2002, the Real Clear Politics average of the last batch of polls taken had Republicans winning the popular vote 47.7 percent to 46 percent, and sure enough Republicans won the popular vote for the House of Representatives, except that it was by an even greater margin than forecast, 49.6 percent to 45 percent.
In 2006, the average of polls had Democrats leading the generic Congressional ballot 52.1 percent to 40.6 percent, although that overstated the outcome a bit, with Democrats winning the House popular vote 52 percent to 44 percent.
In 2010, the average of polls had Republicans leading 50.7 percent to 41.3 percent, also overstated a bit, with the outcome being 51.6 percent to 44.8 percent.
In 2014, the average of polls had Republicans ahead, 45.6 percent to 43.2 percent, and Republicans won by 51.4 percent to 45.7 percent.
In 2018, the average of polls had Democrats ahead, 49.7 percent to 42.4 percent, and Democrats won by a margin of 53.3 percent to 44.9 percent.
And in 2022, the average of polls had Republicans ahead 48 percent to 45.5 percent, and Republicans won 50.6 percent to 47.8 percent.
In midterm elections dating back to 1906 through 2022, the party that occupied the White House lost seats in the House 27 out of 30 times, or 90 percent of the time, and in years with losses those averaged 34 seats. It was only overcome in 1934, 1998 and 2002, with the Great Depression, Monica Lewinsky and the Sept. 11, 2001 terrorist attacks acting as exigent events.
The general rule favoring the opposition in midterms is all James Madison’s constitutional scheme of periodic elections, explicitly designed to frustrate the ability of majorities to get things done. But midterms are generally a turnout affair, where the opposition party, being out of power, simply has more of a motivation to vote, and so they tend to do relatively better, picking up seats, but not always majorities.
So, that’s the advantage wielded generally by the opposition power during Congressional midterms, which might make Democrats’ current narrow margin in the generic ballot somewhat worrisome. On average, Trump still has his highest approval of his entire political career at 46.5 percent — higher than in 2017, 2018, 2019, and 2020 — while public approval of Democrats generally has been cratering.
Expect Republicans to emphasize their advantage on issues like illegal immigration, the border, and social issues including the participation of biological males in female sports.
Inflation, still the top issue among voters, continues its three-year decline and so if anything could look good for Trump and Republicans, provided incomes and wages continuing outpacing any consumer price increases. Other economic headwinds might come in the form of higher unemployment, a slowdown, or even a recession, while labor shortages might mitigate any downturn.
There are also exigent factors that can arise and impact how the midterms go. Stay tuned.
Robert Romano is the executive director of Americans for Limited Government, a conservative 501(c)(4) nonprofit organization that says it is dedicated to restoring constitutionally limited government, allowing individuals to pursue life, liberty, and happiness.
OPINION: America’s worsening image should be a concern
America’s image in much of the world is getting worse, according to a recent survey by the Pew Research Center. That should be a concern for Americans. Our image affects our effectiveness as a world leader and our ability to advance our national interests. The survey, conducted this year, found that people in other countries
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
America’s image in much of the world is getting worse, according to a recent survey by the Pew Research Center. That should be a concern for Americans. Our image affects our effectiveness as a world leader and our ability to advance our national interests.
The survey, conducted this year, found that people in other countries were almost evenly split in whether they had positive or negative views of the United States. However, the percentage with a negative view of America has grown in most nations in the survey.
From the end of World War II until early in the 21st Century and beyond, the U.S. was the undisputed world leader by most measures. We helped create and lead the institutions of the postwar international order, which produced a sustained period of peace and prosperity. Certainly, there were times when our policies were unpopular or misguided. For the most part, however, we could think of America as a model that much of the world admired, especially our allies.
But things have shifted in recent years. When I meet with people from around the world, I find that they still care about the U.S. and are interested in what we think, but they are less likely to look to us as an example. The Pew Survey, which included 24 countries in all parts of the world, confirms that. The share of the population with a negative view of the U.S. has risen in almost every country. The number who view us positively has declined.
Our worst rating is in Sweden, where four in five people have a negative view. Elsewhere in Europe, including in France, Germany and Spain, over 60 percent have negative views of the U.S. The biggest shift from positive to negative in the past year came from our neighbors, Mexico and Canada. Our highest approval, 83 percent, is in Israel. Only in Israel, Nigeria and Turkey have views of the U.S. improved.
It’s concerning that majorities in 12 of the surveyed nations see China as the world’s leading economic power, compared to only eight nations for the U.S. We have the world’s largest economy, as measured by gross domestic product, but our economic image doesn’t reflect that reality. This comes at a time when China is pushing its state-controlled economy as a better model for the world than our free-market system. The same holds true for views of American democracy. According to the survey, people are split on whether democracy is working well in the U.S. In many countries, including some European allies, majorities say it is functioning poorly.
Clearly, views of the U.S. reflect views of President Donald Trump. According to the survey, conservatives are now more likely than liberals to view the U.S. positively. But majorities lack confidence in Trump’s ability to handle world affairs, especially climate change and the Russia-Ukraine war. (It’s too early to say how bombing Iranian nuclear sites [and negotiating a ceasefire between Israel and Iran}will affect America’s image in the long run).
Trump would no doubt argue that it doesn’t matter if people in other countries view the United States positively. He would say it’s more important that they respect us, and that he can make deals that favor the U.S. He has a point: Foreign affairs aren’t a popularity contest, and our leaders need to look out for America’s interests.
But most of us believe the United States should be a force for good in the world. We are the wealthiest and most powerful nation in history, and with that comes responsibility. Our 250-year experiment with democracy has inspired countless countries. It’s important that we live up to our national ideals and our professed belief in freedom, democracy and human rights. Surveys that find our image getting worse should be a warning.
Lee Hamilton, 94, is a senior advisor for the Indiana University (IU) Center on Representative Government, distinguished scholar at the IU Hamilton Lugar School of Global and International Studies, and professor of practice at the IU O’Neill School of Public and Environmental Affairs. Hamilton, a Democrat, was a member of the U.S. House of Representatives for 34 years (1965-1999), representing a district in south-central Indiana.
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.